Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Research

Cannabis use and dependence among festival attendees: results from the French OCTOPUS survey

Authors: Sarah Chaaban, Marion Istvan, Benoit Schreck, Pauline Laigo, Morgane Rousselet, Marie Grall-Bronnec, Stéphanie Pain, Caroline Victorri-Vigneau

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Chronic use of cannabis is associated with an increased risk of psychosocial, mental and physical health impairments. Sociohealth institutions reach a very limited proportion of cannabis users in need of treatment. Using data collected from festival attendees, this study aimed to estimate the prevalence of dependent cannabis users and to characterize cannabis dependence.

Methods

We used data from the cross-sectional OCTOPUS survey carried out at 13 music events in the French department of Loire-Atlantique between July 2017 and July 2018. 383 participants aged 18 or older underwent a face-to-face interview about their basic sociodemographics, tobacco use, alcohol use and past-year substance use. Using the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria, we estimated the prevalence of dependent cannabis users and characterized their dependence.

Results

More than two-thirds of participants reported that they had used cannabis in the past 12 months. Among 194 regular cannabis users (at least monthly), 63.4% were dependent. At least 40% of regular users reported health and/or social consequences of cannabis use. Compared to nondependent cannabis users, dependent cannabis users were more likely to be stimulant users and hallucinogen users.

Conclusions

Dependent cannabis use is common among festival attendees, especially among stimulant or hallucinogen users. Festival settings may be important arenas for i) implementing efficient harm reduction measures to prevent dependence and ii) providing information on care structures and promoting the use of care to dependent users. In addition, healthcare professionals should be aware of trends in polysubstance use among dependent cannabis users.
Appendix
Available only for authorised users
Literature
1.
Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327–60.PubMedCrossRef
2.
3.
4.
5.
Galván G, Guerrero-Martelo M, Vásquez De la Hoz F. Cannabis: A Cognitive Illusion. Rev Colomb Psiquiatr. 2017;46(2):95–102.PubMedCrossRef
6.
Karila L, Roux P, Rolland B, Benyamina A, Reynaud M, Aubin HJ, et al. Acute and long-term effects of cannabis use: a review. Curr Pharm Des. 2014;20(25):4112–8.PubMedCrossRef
7.
Palamar JJ, Acosta P, Le A, Cleland CM, Nelson LS. Adverse drug-related effects among electronic dance music party attendees. Int J Drug Policy. 2019;73:81–7.PubMedPubMedCentralCrossRef
8.
Schmid Y, Scholz I, Mueller L, Exadaktylos AK, Ceschi A, Liechti ME, et al. Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland. Drug Alcohol Depend. 2020;206:107726.PubMedCrossRef
9.
Barratt MJ, Hughes CE, Ferris JA, Winstock AR. Australian music festival attendees who seek emergency medical treatment following alcohol and other drug use: a global drug survey data report. Melbourne: Social and Global Studies Centre, RMIT University; 2019.
10.
Hall W, Degenhardt L. The adverse health effects of chronic cannabis use. Drug Test Anal. 2014;6(1–2):39–45.PubMedCrossRef
11.
Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol. 2007;118(2):141–4.PubMedCrossRef
12.
Castle DJ, Murray R. Marijuana and madness: psychiatry and neurobiology. New York: Cambridge University Press; 2004. p. 218.CrossRef
13.
14.
Jouanjus E, Raymond V, Lapeyre-Mestre M, Wolff V. What is the current knowledge about the cardiovascular risk for users of Cannabis-based products? A systematic review. Curr Atheroscler Rep. 2017;19(6):26.PubMedCrossRef
15.
16.
17.
Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Psychiatry. 2018;5(12):987–1012.CrossRef
18.
Leung J, Chan GCK, Hides L, Hall WD. What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict Behav. 2020;109:106479.PubMedCrossRef
19.
Chung T, Cornelius J, Clark D, Martin C. Greater prevalence of proposed ICD-11 alcohol and Cannabis dependence compared to ICD-10, DSM-IV, and DSM-5 in treated adolescents. Alcohol Clin Exp Res. 2017;41(9):1584–92.PubMedPubMedCentralCrossRef
20.
Hines LA, Freeman TP, Gage SH, Zammit S, Hickman M, Cannon M, et al. Association of High-Potency Cannabis use with Mental Health and Substance use in adolescence. JAMA Psychiatry. 2020;77(10):1044.PubMedPubMedCentralCrossRef
21.
Freeman TP, Craft S, Wilson J, Stylianou S, ElSohly M, Di Forti M, et al. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Addiction. 2021;116(5):1000–10.PubMedCrossRef
22.
Spilka S, Richard JB, Le Nézet O, Janssen E, Philippon A, Shah J, et al. Les niveaux d’usage des drogues illicites en France en 2017. Tendances. 2018;128:8.
23.
Hesse M, Tutenges S. Dependent cannabis users at a music festival – prevalence and correlates. Drugs: Educ Prev Policy. 2011;18(6):433–7.
24.
25.
Mohr ALA, Friscia M, Yeakel JK, Logan BK. Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees. Forensic Sci Int. 2018;282:168–78.PubMedCrossRef
26.
Erickson TB, Aks SE, Koenigsberg M, Bunney EB, Schurgin B, Levy P. Drug use patterns at major rock concert events. Ann Emerg Med. 1996;28(1):22–6.PubMedCrossRef
27.
Moore K, Miles S. Young people, dance and the sub-cultural consumption of drugs. Addiction Research & Theory - Addict Res Theory. 2004;1(12):507–23.CrossRef
28.
Lim MSC, Hellard ME, Hocking JS, Spelman TD, Aitken CK. Surveillance of drug use among young people attending a music festival in Australia, 2005-2008. Drug Alcohol Rev. 2010;29(2):150–6.PubMedCrossRef
29.
Hesse M, Tutenges S. Music and substance preferences among festival attendants. Drugs Alcohol Today. 2012;12(2):82–8.CrossRef
30.
Van Havere T, Vanderplasschen W, Lammertyn J, Broekaert E, Bellis M. Drug use and nightlife: more than just dance music. Subst Abuse Treat Prev Policy. 2011;27(6):18.CrossRef
31.
Fox J, Smith A, Yale A, Chow C, Alaswad E, Cushing T, et al. Drugs of abuse and novel psychoactive substances at outdoor music festivals in Colorado. Subst Use Misuse. 2018;53(7):1203–11.PubMedCrossRef
32.
Palamar JJ, Keyes KM. Trends in drug use among electronic dance music party attendees in new York City, 2016-2019. Drug Alcohol Depend. 2020;1(209):107889.CrossRef
33.
Miller P, Curtis A, Jenkinson R, Droste N, Bowe SJ, Pennay A. Drug use in Australian nightlife settings: estimation of prevalence and validity of self-report. Addiction. 2015;110(11):1803–10.PubMedCrossRef
34.
Legleye S, Beck F. Sociabilités, styles musicaux et usages de substances psychoactives à 18 ans. Psychotropes. 2003;9(3–4):11–35.CrossRef
35.
Palamar JJ, Griffin-Tomas M, Ompad DC. Illicit drug use among rave attendees in a nationally representative sample of US high school seniors. Drug Alcohol Depend. 2015;152:24–31.PubMedPubMedCentralCrossRef
36.
Feltmann K, Elgán TH, Strandberg AK, Kvillemo P, Jayaram-Lindström N, Grabski M, et al. Illicit drug use and associated problems in the nightlife scene: a potential setting for prevention. IJERPH. 2021;18(9):4789.PubMedPubMedCentralCrossRef
37.
Jenkinson R, Bowring A, Dietze P, Hellard M, Lim MSC. Young risk takers: alcohol, illicit drugs, and sexual practices among a sample of music festival attendees. J Sex Transm Dis. 2014;14(2014):1–6.
38.
Hoareau E. L’impact de la réduction des risques dans les espaces festifs techno. Psychotropes. 2007;13(2):27–48.CrossRef
39.
Istvan M, Bresdin V, Mainguy M, Laigo P, Grall-Bronnec M, Eudeline V, et al. First results of the French OCTOPUS survey among festival attendees: a latent class analysis. Harm Reduct J. 2023;20(1):43.PubMedPubMedCentralCrossRef
40.
Victorri-Vigneau C, Hardouin JB, Rousselet M, Gerardin M, Guerlais M, Guillou M, et al. Multicentre study for validation of the French addictovigilance network reports assessment tool. Br J Clin Pharmacol. 2016;82(4):1030–9.PubMedPubMedCentralCrossRef
41.
Micallef J, Mallaret M. Les 25 ans des centres d’évaluation et d’information sur la pharmacodépendance-addictovigilance. Therapies. 2016;71(4):375–8.CrossRef
42.
43.
44.
45.
46.
Compton WM, Han B, Jones CM, Blanco C. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Drug Alcohol Depend. 2019;204:107468.PubMedPubMedCentralCrossRef
47.
Degenhardt L, Glantz M, Bharat C, Peacock A, Lago L, Sampson N, et al. The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: findings from the Australian National Survey on mental health and wellbeing. Drug Alcohol Rev. 2018;37(4):546–56.PubMedPubMedCentralCrossRef
48.
Bonner WIA, Andkhoie M, Thompson C, Farag M, Szafron M. Patterns and factors of problematic marijuana use in the Canadian population: evidence from three cross-sectional surveys. Can J Public Health. 2017;108(2):e110–6.PubMedPubMedCentralCrossRef
49.
Hayley AC, Stough C, Downey LA. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: evaluating comorbidity in a population-based sample. Eur Neuropsychopharmacol. 2017;27(8):732–43.PubMedCrossRef
50.
Millar SR, Mongan D, O’Dwyer C, Smyth BP, Perry IJ, Galvin B. Relationships between patterns of cannabis use, abuse and dependence and recent stimulant use: Evidence from two national surveys in Ireland. Troup LJ, editor. PLoS One. 2021;16(8):e0255745.PubMedPubMedCentralCrossRef
51.
Butterworth P, Slade T, Degenhardt L. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of mental health and well-being: predictors of cannabis use and CUD. Drug Alcohol Rev. 2014;33(5):555–64.PubMedCrossRef
52.
Parrott AC, Milani RM, Gouzoulis-Mayfrank E, Daumann J. Cannabis and ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. J Neural Transm. 2007;114(8):959–68.PubMedCrossRef
53.
Secades-Villa R, Garcia-Rodríguez O, Jin CJ, Wang S, Blanco C. Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy. 2015;26(2):135–42.PubMedCrossRef
54.
Bahji A, Stephenson C, Tyo R, Hawken ER, Seitz DP. Prevalence of Cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and Meta-analysis. JAMA Netw Open. 2020;3(4):e202370.PubMedPubMedCentralCrossRef
55.
Pellegrino AJ, Duck KD, Kriescher DPJ, Shrake ME, Phillips MM, Lalonde TL, et al. Characterizing symptoms of Cannabis use disorder in a sample of college students. J Drug Issues. 2020;50(4):524–37.PubMedPubMedCentralCrossRef
56.
Blanco C, Ogburn E, Pérez de los Cobos J, Lujan J, Nunes EV, Grant B, et al. DSM-IV criteria-based clinical subtypes of cannabis use disorders: results from the National Epidemiological Survey on alcohol and related conditions (NESARC). Drug Alcohol Depend. 2008;96(1–2):136–44.PubMedCrossRef
57.
Santaella-Tenorio J, Levy NS, Segura LE, Mauro PM, Martins SS. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002–2016. Drug Alcohol Depend. 2019;205:107621.PubMedPubMedCentralCrossRef
58.
59.
Compton WM, Dawson DA, Goldstein RB, Grant BF. Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, Cannabis, cocaine and alcohol. Drug Alcohol Depend. 2013;132:387.PubMedPubMedCentralCrossRef
60.
Goldstein RB, Chou SP, Smith SM, Jung J, Zhang H, Saha TD, et al. Nosologic comparisons of DSM-IV and DSM-5 alcohol and drug use disorders: results from the National Epidemiologic Survey on alcohol and related conditions–III. J Stud Alcohol Drugs. 2015;76(3):378–88.PubMedPubMedCentralCrossRef
61.
Livne O, Shmulewitz D, Stohl M, Mannes Z, Aharonovich E, Hasin D. Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users. Drug Alcohol Depend. 2021;10(227):108958.CrossRef
62.
Bouquet E, Pain S, Eiden C, Jouanjus E, Richard N, Fauconneau B, et al. Adverse events of recreational cannabis use reported to the French addictovigilance network (2012–2017). Brit Jnl Clinical Pharma. 2021;87(10):3925–37.CrossRef
63.
Miller PG, Sønderlund AL. Using the internet to research hidden populations of illicit drug users: a review. Addiction. 2010;105(9):1557–67.PubMedCrossRef
64.
65.
Hoch E, Preuss UW, Ferri M, Simon R. Digital interventions for problematic Cannabis users in non-clinical settings: findings from a systematic review and Meta-analysis. Eur Addict Res. 2016;22(5):233–42.PubMedCrossRef
66.
Champion KE, Newton NC, Barrett EL, Teesson M. A systematic review of school-based alcohol and other drug prevention programs facilitated by computers or the internet. Drug Alcohol Rev. 2013;32(2):115–23.PubMedCrossRef
67.
68.
Spechler PA, Allgaier N, Chaarani B, Whelan R, Watts R, Orr C, et al. The initiation of cannabis use in adolescence is predicted by sex-specific psychosocial and neurobiological features. Eur J Neurosci. 2019;50(3):2346–56.PubMedCrossRef
Metadata
Title
Cannabis use and dependence among festival attendees: results from the French OCTOPUS survey
Authors
Sarah Chaaban
Marion Istvan
Benoit Schreck
Pauline Laigo
Morgane Rousselet
Marie Grall-Bronnec
Stéphanie Pain
Caroline Victorri-Vigneau
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18496-9

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue

Systematic Review

Factors influencing risk perception during Public Health Emergencies of International Concern (PHEIC): a scoping review

Research

Exploring the relationship between loneliness and volunteering amongst Australian adults: a cross-sectional study

Research

Exploration of the factors influencing the quality of life among adolescents during the COVID-19 pandemic: the data from a cross-sectional study in Shandong

Research

The significance of managers’ knowledge of common mental disorders on managerial stigma towards employee depression: a cross-sectional study in Sweden

Research

Validation of the inventory: lockdown and its impact on the university Community

Research

Implementation of REDCap mobile app in an oral HIV clinical study